v3.20.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
12 Months Ended
Aug. 31, 2020
Aug. 31, 2019
Cash flows used in operating activities    
Net loss and comprehensive loss $ (4,084,613) $ (4,158,413)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 1,139,270 626,692
Depreciation and amortization (Note 8, 9, 10) 112,750 60,550
Inventory writeoff (Note 8) 8,240 7,182
Bad debt expense 50,000 75,000
Noncash right of use lease expense (34,831)  
Realized loss on disposal of marketable securities (Note 19) 18,198  
Unrealized loss on marketable securities (Note 19) 19,893 16,434
Common shares issued for services 100,000 234,500
Warrants issued for services 168,833 52,817
Change in working capital    
Accounts receivable (90,780) (138,644)
Inventory 4,213 (47,345)
Prepaid expenses and deposits (113,168) 124,805
Accounts payable and accrued liabilities (49,491) 100,626
Due to related parties 10,608 40,241
Operating lease liability 33,342  
Deferred revenue 44,255  
Net cash used in operating activities (2,663,281) (3,005,555)
Cash flows used in investing activities    
Sale of marketable securities (Note 20) 6,802  
Intellectual Property (33,645) (122,982)
Property & equipment 0 (646,183)
Net cash used in investing activities (26,843) (769,165)
Cash flows from financing activities    
Investment from NCI   1,000,000
Long Term Loan 30,670  
Proceeds from issuance of equity 2,668,056 2,332,683
Net cash from financing activities 2,698,726 3,332,683
Decrease in cash and cash equivalents 8,602 (442,037)
Cash and cash equivalents, beginning of year 1,285,147 1,727,184
Cash and cash equivalents, end of year 1,293,749 1,285,147
Supplemental information of cash flows:    
Income taxes paid in cash $ (12,978) 13,919
Reclassification of NCI to additional paid in capital on acquisition   $ 833,333

Source